Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

This study is currently recruiting participants.

Verified March 2013 by National Cancer Institute (NCI)

Sponsor:

Collaborators:

Southwestern Oncology Group (SWOG)

North Central Cancer Treatment Group

Cancer and Leukemia Group B

NCIC Clinical Trials Group

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00324805

First received: May 10, 2006

Last updated: March 18, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2015 (Final data collection date for primary outcome measure)